Why is the Dept. of Justice Investigating Zantac Maker?

December 23, 2020 / 7:16 am

Zantac and generic forms of this medication, both prescription and over the counter, have faced significant recalls over the last year. Now, The US Department of Justice (DOJ) is investigating two Zantac manufacturers. The DOJ is attempting to determine whether or not the drug manufacturers violated federal laws while selling the medication. Here, we want to discuss this ongoing investigation as well as give a brief overview of the Zantac recall.

Why have Zantac and generic ranitidine been recalled?

Zantac and other ranitidine medications have faced massive recall over the last year after investigations uncovered unsafe levels of N-Nitrosodimethylamine (NDMA), a probable human carcinogen. In a statement released on April 1, 2020, The US Food and Drug Administration (FDA) asked that all Zantac and ranitidine products be removed from the market immediately.

According to the FDA, “The agency has determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity.”

Testing continued to show that NDMA levels increase inside these medications under normal storage temperatures and conditions, though the level of NDMA significantly increases at higher storage temperatures.

What is going on with the DOJ investigation?

The Department of Justice is investigating GlaxoSmithKline (GSK) and Sanofi, two of the Zantac manufacturers. GlaxoSmithKline is the original manufacturer of Zantac, and Sanofi currently holds the rights to Zantac brands in the United States. Both of these companies currently sell generic forms of ranitidine throughout the country.

Specifically, the DOJ is seeking to have several questions answered:

  • When did these manufacturers learn about unsafe NDMA levels in the medication?
  • When did the manufacturers learn that Zantac’s active ingredient can breakdown in the stomach, creating additional NDMA?
  • Did the manufacturers conceal cancer risks associated with Zantac?

Answers to these questions could reveal potential violations of the False Claims Act (FCA). The FCA was signed into law in the 1800s and made it illegal for manufacturers to provide sub-standard goods and services to the US government. Typically, the FCA is referred to as a whistleblower law. If it is discovered, through the course of the investigation, that these companies knew about the dangers posed by Zantac and the generic forms of the medication, and failed to disclose this information to the government, they could face significant repercussions.

Call our respected product liability team today

If you or somebody you care about has and diagnosed with cancer, and you think Zantac caused your illness, seek assistance from the nationally recognized product liability team at Colson Hicks Eidson as soon as possible. Our firm will conduct a complete investigation into your illness and your Zantac use so we can establish a link between the two. Our goal is to secure the compensation you are entitled to. When you need a Zantac attorney in Florida or throughout the United States, you can contact us for a free consultation by clicking here or by calling us at 305-476-7400.

Trending Stories

February 6, 2025

Latest Updates
and Insights from Colson

Related News & Case Studies

Colson Hicks Eidson was proud to represent Brookfield Properties, owner of the Ritz-Carlton Hotel property in Ft. Lauderdale, during trial in a long-running case brought by David J. Stern, a unit owner in the residential condominium portion of the property, who alleged water intrusion and property damage in his unit. After a three-and-one-half week jury trial in Broward County Circuit Court, the jury returned an across-the-board verdict in favor of our client. 

“Our firm was proud to represent Brookfield Properties in this hard-fought trial, and we are pleased that the jury delivered a clear and decisive verdict in our client’s favor,” Curtis Miner said.

Congratulations to our trial team Curtis Miner, Zachary Lipshultz, Aziza Elayan, and Michelle Roberto, joined by Jodi Kleinick from Paul Hastings.  

About Colson Hicks Eidson

Colson Hicks Eidson is a renowned law firm based in Miami, Florida, that is recognized as one of the top trial firms in the United States. Built on a foundation of over 50 years of dedication forging strong client relationships, Colson Hicks Eidson handles local, national, and international litigation, with cases spanning from Miami, Florida, and throughout the United States, to matters in the Caribbean, Central America, South America, and Europe. Learn more at: www.colson.com.

MIAMI (January 22, 2025) – Colson Hicks Eidson is thrilled to announce that three of its partners have been named in the 2025 Lawdragon 500 Leading Lawyers in America. This impressive guide selects its lawyers through Lawdragon’s independent journalistic research and submissions process.

Now in its 20th year, Lawdragon 500 Leading Lawyers in America recognized Colson Hicks Eidson attorneys Julie Braman Kane, Roberto Martínez, and Curtis Miner for their exceptional work in litigation, plaintiff class action litigation, and white-collar practice areas.

Julie’s work has made a significant difference in the lives of her clients. She has represented plaintiffs in personal injury, commercial, and class action litigation, participating in cases securing hundreds of millions of dollars for clients, including recent resolutions of a data breach class action as well as multiple personal injury and wrongful death matters.

Curtis has tried cases to jury verdicts against auto manufacturers and airlines and has obtained sizable settlements in individual and plaintiffs’ class action litigation, having served as Class Counsel in cases against financial institutions arising out of Ponzi schemes and as part of court-appointed leadership counsel in the Takata Airbags Products Liability Litigation MDL, securing over $1.5 billion in settlements for classes of millions of vehicle owners.

Roberto has secured significant client wins in high-profile cases, including participating in settlements and judgments totaling in excess of $6 billion.

Click here to read the full guide on Lawdragon.

About Colson Hicks Eidson

Colson Hicks Eidson is a renowned law firm based in Miami, Florida, that is recognized as one of the top trial firms in the United States. Built on a foundation of over 50 years of dedication forging strong client relationships, Colson Hicks Eidson handles local, national, and international litigation, with cases spanning from Miami, Florida, and throughout the United States, to matters in the Caribbean, Central America, South America, and Europe. Learn more at: www.colson.com.

A federal judge in Florida denied UnitedHealthcare’s motion to dismiss a lawsuit brought by a cancer patient seeking coverage for proton beam radiation therapy to treat his tongue cancer. The patient, Carlos Morera, alleges the insurer wrongfully denied benefits under his healthcare plan, forcing him to pay approximately $195,000 out of pocket for the treatment.

Stephanie A. Casey, a partner at Colson Hicks Eidson, represents Morera and successfully argued that the case should proceed.

“We look forward to presenting the merits of this case at trial. Proton beam radiation therapy has long been recognized as the standard of care for these types of cancers,” she said.

The court’s decision allows Morera to continue his fight to recover treatment costs. Read more about this case on Law360 here.

MIAMI (November 20, 2024) – Colson Hicks Eidson has been named to the 2025 edition of the “Best Law Firms” by Best Lawyers®, recognized at both the national and metropolitan levels. Seven of the firm’s attorneys were also named to the 2025 edition of Best Lawyers® across multiple practice areas.

“We are committed to delivering exceptional representation for our clients. This continued recognition of our firm’s core practice areas highlights the success of our efforts,” said Dean C. Colson, Managing Partner of Colson Hicks Eidson.

Best Lawyers® ranks top lawyers and law firms through a peer review process, using feedback from lawyers, clients, and professional references, along with firm data. Rankings are organized into regional and national tiers.

National Tier 2

● Mass Tort Litigation / Class Actions – Plaintiffs

Metropolitan Tier 1

Miami

● Bet-the-Company Litigation
● Commercial Litigation
● Criminal Defense: White-Collar
● Insurance Law
● Mass Tort Litigation / Class Actions – Plaintiffs
● Medical Malpractice Law – Defendants
● Medical Malpractice Law – Plaintiffs
● Personal Injury Litigation – Plaintiffs
● Product Liability Litigation – Plaintiffs

Metropolitan Tier 2

Miami

● Professional Malpractice Law – Defendants

About Colson Hicks Eidson

Colson Hicks Eidson is a renowned law firm based in Miami, Florida, that is recognized as one of the top trial firms in the United States. Built on a foundation of over 50 years of dedication forging strong client relationships, Colson Hicks Eidson handles local, national, and international litigation, with cases spanning from Miami, Florida, and throughout the United States, to matters in the Caribbean, Central America, South America, and Europe. Learn more at: www.colson.com.

MIAMI (November 12, 2024) – Colson Hicks Eidson announced today that managing partner Dean Colson has been recognized in Florida Trend’s 2024 edition of the Florida 500, a publication highlighting the 500 most influential executives across various economic sectors in the state.

The publication notes that Dean’s credentials include chairing the state university system’s Board of Governors, the board of trustees for Florida International University, and the board of trustees for the University of Miami.

Dean is renowned as a top trial lawyer in the U.S. with 40 years of experience in complex civil litigation, personal injury, product liability, and professional malpractice. He has successfully represented large plaintiff classes and handled multimillion-dollar cases, including high-profile litigation such as the AeroPeru airplane crash and a Ponzi scheme settlement.

Dean has demonstrated a strong commitment to community service through various leadership roles. He has been actively involved with the Institute of Contemporary Art in Miami, supporting access to the arts. He’s also been president of the Orange Bowl Committee and chaired the Super Bowl XXIX Host Committee. He served on the Florida Commission on Ethics and chaired the Florida Supreme Court Judicial Nominating Commission. He previously served as President of the Dade County Bar Association and as a distinguished member of the Florida Bar Board of Governors. Most recently, the Coral Gables Community Foundation recognized Dean at its 2024 Annual Gala with the Education Award.

About Colson Hicks Eidson

Colson Hicks Eidson is a renowned law firm based in Miami, Florida, that is recognized as one of the top trial firms in the United States. Built on a foundation of over 50 years of dedication to forging strong client relationships, Colson Hicks Eidson handles local, national, and international litigation, with cases spanning from Miami, Florida, and throughout the United States, to matters in the Caribbean, Central America, South America, and Europe. Learn more at: www.colson.com.

The U.S. Attorney’s Office for the Southern District of Florida has launched a new Whistleblower Non-Prosecution Pilot Program. It reinforces the recent efforts of the Department of Justice Criminal Division’s new Corporate Whistleblower Awards Pilot Program.

The local pilot program offers non-prosecution agreements in exchange for the early and voluntary self-disclosures of criminal conduct.  The Department’s pilot program offers financial rewards to a whistleblower who provides original and truthful information about corporate misconduct that results in a successful forfeiture.  

Both pilot programs require the prompt disclosure of truthful and complete information.   

At Colson Hicks Eidson, our attorneys have advised and represented clients across the full range of internal investigations, government inquiries, enforcement actions, whistleblower actions, and civil and criminal trials.  For further information, contact us at 305-476-7400 or info@colson.com.